In the 30 patients with Gleason score 7 who underwent miRNA screening, median age was 65 years (range 57–71), median PSA 18.8 ng/mL (range 5–79), median tumor size 22 mm (range 3–45), 21% experienced CF and 14% were dead of prostate cancer. This evidence concerns the gene KLK3 and neoplasm.